Is a complete SHE/300254 research report available?

No complete published report is available for she/300254 (SHE/300254) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

she/300254 stock profile: metrics, valuation and analysis

Market cap	2.2B
Revenue (ttm)	849.7M
Net income (ttm)	28.8M
EPS (ttm)	CN¥0.12
Shares out	256.1M
P/E (trailing)	75.4x
Volume	663,900
Beta	0.46

All SHE/300254 indicators

Market & fundamental data

Available fields

230

Groups with data

Currency

CNY

Showing 230 of 230 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	China
Country code	CN
Employees	1,162
Employees Change	-34%
Employees Change Percent	-2.84
Enterprise value	CNY 2.7B
Exchange	Shenzhen Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Industry PE	35.4
Industry PE Fwd	17.69
Isin	CNE1000016D0
Last refreshed	2026-09-08
Market cap	CNY 2.2B
Price	CNY 8.71
Price currency	CNY
Rev Per Employee	731,217.61x
Sector	Healthcare
Sector PE	40.4
Sector PE Fwd	20.98
Sic	2834
Symbol	she/300254
Website	https://www.cy-pharm.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	1.29%
EV Earnings	94.57x
EV/EBIT	27.12x
EV/EBITDA	16.96x
EV/FCF	21.58x
EV/Sales	3.2x
FCF yield	5.66%
P/B ratio	4.23x
P/E ratio	75.41x
P/S ratio	2.62x
PE Ratio10 Y	111.98x
PE Ratio3 Y	95.85x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	11.8%
EBITDA Margin	17.94%
FCF margin	14.83%
Gross margin	66.09%
Gross Profit	CNY 561.5M
Gross Profit Growth	1.46%
Gross Profit Growth Q	-10.73%
Gross Profit Growth3 Y	1.78%
Gross Profit Growth5 Y	-1.71%
Net Income	CNY 28.8M
Net Income Growth	217.1%
Net Income Growth Qo Q	-71.77%
Net Income Growth Quarters	1%
Net Income Growth Years	0%
Pretax Margin	8.76%
Profit Margin	3.38%
Profit Per Employee	CNY 24,747
Profitable Quarters	CNY 4
Profitable Years	3
ROA	4.14
Roa5y	1.33
ROCE	9.94
ROE	9.85
Roe5y	0.86
ROIC	7.39
Roic5y	2.59

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-8.19%
Cagr15y	-2.87%
Cagr1y	-20.12%
Cagr3y	3.14%
Cagr5y	4.03%
Div CAGR3	-26.32%
Div CAGR5	-32.13%
EPS Growth	206.2
EPS Growth Qo Q	-71.81
EPS Growth Quarters	1
EPS Growth Years	0
FCF Growth	915.3%
FCF Growth Q	556.14%
FCF Growth Qo Q	319.29%
FCF Growth3 Y	87.82%
FCF Growth5 Y	58.04%
OCF Growth	371.49%
OCF Growth Q	246.13%
OCF Growth Qo Q	184.17%
OCF Growth10 Y	32.87%
OCF Growth3 Y	52.1%
OCF Growth5 Y	27.61%
Revenue Growth	3.81x
Revenue Growth Q	-6.89x
Revenue Growth Qo Q	2.46x
Revenue Growth Years	2x
Revenue Growth3 Y	2.47x
Revenue Growth5 Y	-1.39x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CNY 0.56
Assets	CNY 1.5B
Cash	CNY 96.8M
Current Assets	CNY 518.3M
Current Liabilities	CNY 519.8M
Debt	CNY 511.1M
Debt EBITDA	CNY 3.19
Debt Equity	CNY 0.97
Debt FCF	CNY 4.06
Equity	CNY 527M
Interest Coverage	10.33
Liabilities	CNY 1B
Long Term Assets	CNY 1B
Long Term Liabilities	CNY 481.9M
Net Cash	CNY -414.4M
Net Cash By Market Cap	CNY -18.6
Net Debt EBITDA	CNY 2.72
Net Debt Equity	CNY 0.79
Net Debt FCF	CNY 3.29
Tangible Book Value	CNY -48.1M
Tangible Book Value Per Share	CNY -0.2
WACC	5.76

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1
Inventory Turnover	1.78
Net Working Capital	CNY 142.7M
Quick ratio	0.59
Working Capital	CNY -1.5M
Working Capital Turnover	CNY -52.97

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-3.54%
Dividend per share	CNY 0
Last Dividend	CNY 0.02
Payout Ratio	61.24%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-57.46%
1Y total return	-20.11%
200-day SMA	10.52
3Y total return	9.71%
50-day SMA	8.47
50-day SMA vs 200-day SMA	50under200
5Y total return	21.85%
All Time High	54.57
All Time High Change	-84.06%
All Time High Date	2015-06-15
All Time Low	4.92
All Time Low Change	76.83%
All Time Low Date	2021-02-08
ATR	0.41
Beta	0.46
Beta1y	0.45
Beta2y	0.54
Ch YTD	-14.03
High	8.73
High52	15.2
High52 Date	2026-05-11
High52ch	-42.7%
Low	8.61
Low52	6.93
Low52 Date	2026-07-21
Low52ch	25.69%
Ma50ch	2.72%
Price vs 200-day SMA	-17.26%
RSI	47.68
RSI Monthly	46.18
RSI Weekly	42.74
Sharpe ratio	-0.53x
Sharpe Ratio3y	0.28x
Sharpe Ratio5y	0.29x
Sortino ratio	-0.63
Sortino Ratio3y	0.52
Sortino Ratio5y	0.56
Total Return	-3.54%
Tr YTD	-14.03
Tr15y	-35.38%
Tr1m	4.95%
Tr1w	-2.47%
Tr3m	-10.22%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	215,476,864%
Net Borrowing	41,835,848
Shares Insiders	15.85%
Shares Institutions	3.68%
Shares Out	256,058,563
Shares Qo Q	0.13%
Shares Yo Y	3.54%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	15,276,532.85x
Bv Per Share	1.83
CAPEX	CNY -29.4M
Ch10y	-57.97
Ch15y	-37.79
Ch1m	4.95
Ch1w	-2.47
Ch1y	-20.11
Ch3m	-10.22
Ch3y	9.71
Ch5y	21.85
Ch6m	-29.84
Change	0.11%
Change From Open	0.23
Close	8.7
Days Gap	-0.11
Depreciation Amortization	52,170,991
Dollar Volume	5,782,569
Earnings Date	2026-08-25
EBIT	CNY 100.3M
EBITDA	CNY 152.4M
EPS	CNY 0.12
F Score	6
FCF	CNY 126M
FCF EV Yield	4.63x
FCF Per Share	CNY 0.49
Financing CF	-112,215,570
Fiscal Year End	December
Founded	2,005
Goodwill	311,990,498
Graham Number	2.17904
Graham Upside	-74.95
Income Tax	CNY 22.6M
Investing CF	-38,773,983
Is Primary Listing	1
Last Earnings Date	2026-08-25
Last Report Date	2026-06-30
Last Split Date	2016-07-08
Last Split Type	Forward
Ma150	10.5
Ma150ch	-17.17%
Ma20	8.99
Ma20ch	-3.23%
Net CF	4,368,965
Next Earnings Date	2026-09-09
Open	8.69
P FCF Ratio	17.68
P OCF Ratio	14.34
Position In Range	83.33
Ppne	276,381,772
Price Date	2026-09-08
Price EBITDA	CNY 14.61
Relative Volume	0.04x
Revenue	849,674,868x
Tax By Revenue	2.66x
Tax Rate	30.37%
Tr6m	-29.84%
Volume	663,900

SHE/300254 (SHE/300254)

Price

Financial snapshot

Fair-value bridge

Latest news · SHE/300254

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All SHE/300254 indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on SHE/300254

Frequently asked questions